Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, ...

Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GSK’227, now known as risvutatug rezetecan, for the treatment of small-cell lung cancer (SCLC), according to a news ...

Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...